HAEMONETICS CORP (HAE)
2025-06-28 | 2024-12-28 | 2024-09-28 | 2024-06-29 | |
|---|---|---|---|---|
| Net revenues | 321,394 | 348,542 | 345,511 | 336,172 |
| Cost of goods sold | 129,150 | 154,995 | 158,074 | 161,248 |
| Gross profit | 192,244 | 193,547 | 187,437 | 174,924 |
| Selling, general and administrative | 110,719 | 106,459 | 106,946 | 108,248 |
| Research and development | 16,261 | 15,829 | 16,530 | 14,449 |
| Amortization of acquired intangible assets | 11,392 | 12,230 | 12,264 | 12,471 |
| Total operating expenses | 138,372 | 134,518 | 135,740 | 135,168 |
| Operating income | 53,872 | 59,029 | 51,697 | 39,756 |
| Interest and other (expense) income, net | -8,703 | -9,112 | -6,993 | 6,957 |
| Income before provision for income taxes | 45,169 | 49,917 | 44,704 | 46,713 |
| Provision for income taxes | 11,138 | 12,400 | 10,873 | 8,340 |
| Net income | 34,031 | 37,494 | 33,831 | 38,373 |
| Basic (in shares) | 48,111,000 | 50,286,000 | 50,898,000 | 50,943,000 |
| Basic income (loss) per share (in dollars per share) | 0.71 | 0.75 | 0.66 | 0.75 |
| Diluted (in shares) | 48,353,000 | 50,639,000 | 51,240,000 | 51,564,000 |
| Diluted income (loss) per share (in dollars per share) | 0.7 | 0.74 | 0.66 | 0.74 |